SAIF Partners IV L.P. - Mar 18, 2025 SCHEDULE 13D/A Report for SINOVAC BIOTECH LTD. Common Shares, par value US$0.001 per share (SVA)

Filing Manager
SAIF Partners IV L.P.
Reporting Manager
SAIF Partners IV L.P.
Security
SINOVAC BIOTECH LTD. Common Shares, par value US$0.001 per share
Symbol
SVA
Shares outstanding
71.9M shares
Disclosed Ownership
10.8M shares
Ownership
15%
Form type
SCHEDULE 13D/A
Date filed
3/19/2025, 06:15 AM
Date of event
Mar 18, 2025
Previous filing
Feb 19, 2025
Next filing
Apr 29, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SAIF Partners IV L.P. 15% 10.8M 10.8M 0 /s/ Andrew Y Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is the General Partner of SAIF Partners IV L.P. 0001472789
SAIF IV GP, L.P. 15% 10.8M 10.8M 0 /s/ Andrew Y Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P.
SAIF IV GP Capital Ltd. 15% 10.8M 10.8M 0 /s/ Andrew Y Yan Director of SAIF IV GP Capital Ltd.